Plain-English translation of NCT07412782 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is evaluating a new ultrasound technology called REMS (Radiofrequency Echographic Multi Spectrometry) to measure bone mineral density in children with conditions that affect bone health. REMS is a safe, radiation-free method that uses sound waves instead of X-rays. Researchers want to understand how well this new technology works in children and compare it to the standard bone density test currently used.
Measuring bone density is important in children because their bones are still developing, and weak bones can lead to fractures. The current standard test uses a small amount of radiation and doesn't always work well in growing children. This study exists to see if REMS is a safer, more accurate alternative that could become the new standard way to check children's bone health.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will come to the hospital for an ultrasound scan of your bones using the REMS technology — a painless procedure similar to a regular ultrasound. The researchers will also ask about your medical history, take some body measurements, and check your growth and development. If you have had a previous bone density test (DXA scan), they may compare the results. The entire study lasts about 12 months, though your individual visit may be shorter.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy